Granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates cellular glucose uptake by decreasing the apparent K m for substrate transport through facilitative glucose transporters on the plasma membrane. Little is known about this signal transduction pathway and the role of the ␣ subunit of the GM-CSF receptor (␣GMR) in modulating transporter activity. We examined the function of phosphatidylinositol 3-kinase (PI 3-kinase) in GM-CSF-stimulated glucose uptake and found that PI 3-kinase inhibitors, wortmannin and LY294002, completely blocked the GM-CSF-dependent increase of glucose uptake in Xenopus oocytes expressing the low affinity ␣GMR and in human cells expressing the high affinity ␣␤GMR complex. We identified a Src homology 3 domain-binding motif in ␣GMR at residues 358 -361 as a potential interaction site for the PI 3-kinase regulatory subunit, p85. Physical evidence for p85 binding to ␣GMR was obtained by co-immunoprecipitation with antibodies to ␣GMR and p85, and an ␣GMR mutant with alteration of the Src homology 3 binding domain lost the ability to bind p85. Experiments with a construct eliminating most of the intracellular portion of ␣GMR showed a 50% reduction in GM-CSF-stimulated glucose uptake with residual activity blocked by wortmannin. Searching for a proximally generated diffusible factor capable of activating PI 3-kinase, we identified hydrogen peroxide (H 2 O 2 ), generated by ligand or antibody binding to ␣GMR, as the initiating factor. Catalase treatment abrogated GM-CSF-or anti-␣GMR antibody-stimulated glucose uptake in ␣GMR-expressing oocytes, and H 2 O 2 activated PI 3-kinase and led to some stimulation of glucose uptake in uninjected oocytes. Human myeloid cell lines and primary explant human lymphocytes expressing high affinity GM-CSF receptors responded to ␣GMR antibody with increased glucose uptake. These results identify the early events in the stimulation of glucose uptake by GM-CSF as involving local H 2 O 2 generation and requiring PI 3-kinase activation. Our findings also provide a mechanistic explanation for signaling through the isolated ␣ subunit of the GM-CSF receptor.
Granulocyte-macrophage colony-stimulating factor (GM-CSF) 1 is an important cytokine involved in the growth and maturation of hematopoietic cells and in regulating host defense functions (1) . The receptor for GM-CSF is composed of two subunits, ␣ (␣GMR) and ␤ (␤GMR), and is found on hematopoietic cells, myeloid progenitors, mature granulocytes, and mononuclear phagocytes (2, 3) . The GM-CSF receptor is also expressed on non-hematopoietic tissues including endothelial cells, oligodendrocytes, placenta, spermatozoa, prostate, and various immortalized cell lines (4 -12) . The isolated ␣GMR binds GM-CSF with low affinity (K d 2-5 nM) and forms a complex with ␤GMR to create the high affinity receptor (K d 30 pM). While the GM-CSF, IL-5, and IL-3 receptors share a common ␤ chain (␤GMR), the ␣ subunit is unique to each receptor and determines the binding specificity and the distinct responses mediated by each ligand (13, 14) . The ␤GMR subunit plays a central role in GM-CSF cell signaling (15) ; however, the ␣ subunit is also required for signaling mediated by the high affinity receptor beyond its role in ligand binding (16, 17) . A direct signaling function for an isolated ␣ subunit was recently elucidated by the finding that the ␣ IL-5 receptor interacts with syntenin, inducing IL-5-mediated transcriptional responses (18) .
It has long been known that cytokines like IL-3 and GM-CSF modulate glucose uptake in hematopoietic cells (19 -24) . Stimulation of cellular glucose uptake by cytokines is believed to be part of their function as survival factors by enhancing the availability of substrate for energy generation required for cell metabolism (25) . Non-hematopoietic cells expressing high affinity GMR and melanoma cells expressing an isolated ␣GMR also respond to GM-CSF by increasing glucose uptake (12, 26) . We previously found that Xenopus oocytes expressing only the isolated ␣GMR respond to GM-CSF with increased glucose uptake (27) . The only physiological signaling role tentatively assigned to the low affinity GM-CSF receptor, independent of the ␤GMR, is the regulation of glucose uptake (22, 27) . The in vivo relevance of GM-CSF in mediating glucose uptake was demonstrated in the development of preimplantation embryos in mice where an isolated ␣GMR is expressed without ␤GMR. Signaling through this low affinity receptor is associated with increased glucose uptake and enhanced proliferation and viability of blastomeres (28) . Studies with bone marrow from ␤GMR-null mice, however, have suggested that ␤GMR may be required for GM-CSF signaling for glucose transport in mouse bone marrow cells (29) .
Neoplastic transformation and viral infection increase cellular glucose uptake through augmented facilitative glucose transporter (GLUT) expression on the cell surface (30 -32) . Similarly insulin and certain growth factors cause increased GLUT translocation to the cell membrane that is dependent on activation of PI 3-kinase and its downstream targets (33, 34) . Up-regulation of glucose transport in a cell model for chronic myeloid leukemia is also mediated via activation of PI 3-kinase (35) . The ability of GM-CSF to decrease the apparent K m of GLUT1 without changing the V max suggests that initial signaling from the GMR results in modulation of the intrinsic properties of the transporters (26, 36, 37) . GM-CSF also signals for increased transport of the oxidized form of vitamin C, as dehydroascorbic acid, through GLUT1 by a similar mechanism (37) . To elucidate this signaling process and the role of the isolated ␣GMR, we undertook experiments in frog oocytes expressing ␣GMR and human cells expressing both the ␣GMR and ␤GMR subunits. The results reported here point to a central role for PI 3-kinase in signaling for increased glucose uptake and indicate that hydrogen peroxide generated proximally at the receptor is a key initial signaling event.
EXPERIMENTAL PROCEDURES
Cell Lines and Culture Methods-293T cells (38) were maintained in high glucose Dulbecco's modified Eagle's medium supplemented with 10% bovine calf serum, 1% sodium pyruvate, 1% L-glutamine, and antibiotics. Neutrophilic and promyelocytic HL-60 cells were maintained in Iscove's modified Dulbecco's medium supplemented with 10% fetal bovine serum, 1% L-glutamine, and antibiotics. Leukopacks from normal donor blood were provided by the New York Blood Center, and the lymphocytes were purified by Ficoll-Hypaque density centrifugation followed by plastic adherence depletion of monocytes/macrophages. U937 cells were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum.
In Vitro Transcription and RNA Injection-Plasmid containing human ␣GMR cDNA cloned in pBluescript (Stratagene) was linearized with NotI. The digested DNA was extracted with phenol and precipitated with ethanol, and RNA was transcribed in vitro (Ambion, Austin, TX). Stage V and VI oocytes were harvested from the ovaries of adult female Xenopus laevis frogs (Nasco, Ft. Atkinson, WI) and cultured in OR2 (Bufferad Inc.) as described previously (27) . After 48 h of culture, 20 ng of capped mRNA in 50 l of diethyl pyrocarbonate water was microinjected into the vegetal pole of the oocytes as described previously (27) . Glucose uptake experiments were performed 48 h postinjection. ␣GMR mutants were generated in pcDNA4/His-V5c (Invitrogen). RNA was generated by in vitro transcription of these plasmids, linearized with XhoI, and injected as described.
2-Deoxy-D-glucose Uptake-The uptake of 2-deoxy-D-glucose (DOG) by Xenopus oocytes was measured as described previously (27) . Briefly, oocytes (15 per group) were incubated with GM-CSF (1 nM) (R&D Systems, Minneapolis, MN) or the antibodies S20 (0.4 g/ml) (recognizing an extracellular epitope of ␣GMR, Santa Cruz Biotechnology, Inc., Santa Cruz, CA), 17A (0.4 g/ml) (recognizing an extracellular epitope of ␣GMR, Sigma), or N20 (0.4 g/ml) (recognizing the extracellular portion of ␤GMR, Santa Cruz Biotechnology, Inc.) at room temperature for 1 h. Oocytes were incubated with 2-deoxy-D- [1,2- 3 H]glucose (PerkinElmer Life Sciences) and DOG to a final concentration of 0.1-0.4 Ci/ml and 0.2 mM, respectively. After 10 min at room temperature, DOG uptake was terminated by dilution with OR2, and the oocytes were washed with cold OR2 medium four times. Oocytes were then lysed in 20 mM Tris-HCl (pH 8.0) containing 0.2% SDS, and the amount of radioactive DOG trapped intracellularly was measured by scintillation counting. The uptake of DOG in HL-60, U937 cells, and human lymphocytes was measured as described above. Catalase (Sigma) was added to a final concentration of 1900 or 3800 units/ml for 5 min before GM-CSF treatment.
Immunoprecipitation of ␣GMR and ␤GMR from Transfected 293T Cells-293T cells were transfected using Superfect (Qiagen) in 100-mm plates at 50% confluence with 5 g of plasmids for ␣GMR, ␣GMR-PA, ␣GMR-A351, or ␣GMR-YA according to the manufacturer's instructions. Forty-eight hours after transfection the cells were harvested and lysed by sonication in lysis buffer (20 mM Tris, 150 mM NaCl, 0.1% Triton X-100) containing protease and phosphatase inhibitor mixtures (Sigma). For immunoprecipitation the samples were centrifuged at 12,000 ϫ g for 10 min at 4°C, and the cleared lysates were further treated with protein A-Sepharose beads (Sigma). Anti-␣GMR antibody S20 was added at 1 g per sample for 2 h, and the antibodies were captured on protein A-Sepharose beads for 2 h at 4°C. The beads were washed with lysis buffer four times, and the proteins were analyzed by immunoblotting. Anti-␣GMR antibodies C18 and S50 and anti-p85 antibody were used for detection of ␣GMR and p85, respectively.
Detection of p85 in HL-60 -Lysates from HL-60 cells with or without treatment with GM-CSF were incubated with 1 g of anti-␣GMR antibody (S20) for 16 h at 4°C on an oscillating platform. Protein G-agarose (20 g) was then added and left for 1 h at 4°C. The protein G beads were collected by centrifugation and washed three times with lysis buffer. The supernatants were removed carefully, and the beads were resuspended with 1ϫ sample loading buffer and heated for 5 min at 95°C before separation by 7.5% SDS-PAGE. Western blotting to analyze the PI 3-kinase (p85) was performed in the following manner. Nonspecific sites were blocked using 5% nonfat milk in Tris-buffered saline before incubating the blot with anti-p85 antibody (Santa Cruz Biotechnology, Inc.) for 16 h at 4°C at a final dilution of 1:1000 in fresh blocking buffer. The membrane was washed three times in Tris-buffered saline, incubated for 1 h at room temperature with anti-mouse IgG, horseradish peroxidase-linked whole antibody (Amersham Biosciences), diluted 1:4000 in blocking buffer, and washed with Trisbuffered saline and 0.1% Tween 20, and proteins were revealed using the ECL detection system (Amersham Biosciences).
Construction of Mutant Plasmids-Human ␣GMR was subcloned into HindIII and NotI sites of pcDNA4/His-V5c (Invitrogen) using the following 5Ј primer: GCCGCAAGCTTAGCACCATGCTTCTCCTGGT GACA-3Ј. The reverse primer for full-length ␣GMR was GATAGTTT-AGCGGCCGCGGTAATTTCCTTCACGGT to generate plasmid ␣GMR. The reverse primer for the carboxyl-terminal deletion ␣GMR-A351 was 5Ј-TTTAAAAGGTTCCTTAGGGCGGCCGCTAAACTATC-3Ј.
Site-specific mutants were generated in the plasmid ␣GMR using a mutagenesis kit (Stratagene). Briefly, ␣GMR-containing plasmid was denatured and annealed with oligonucleotide primers containing the desired mutation. The following primers were used for proline substitution by alanine: forward primer, 5Ј-CTTAGGATACAGCGGCTGTTC-GCAGCAGTTGCACAGATCAAAGACAACTGAAT-3Ј; reverse primer, 5Ј-ATTCAGTTTGTCTTTGATCTGTGCAACTGCTGCGAACA GCCGC-TGTA TCCTAAG-3Ј. For tyrosine substitution by alanine the forward primer was 5Ј-ATCATCTGGGAGGAATTCACCCCAGAGGAAGGGAA-AGGCGCACGCGAAGAGGT-3Ј, and the reverse primer was 5Ј-GACC-TCTTCGCGTGCGCCTTTCCCTTCCTCTGGGGTGAAT TCCTCCCAG-ATGAT-3Ј. The mutagenic primers were incorporated using Pfu Turbo DNA polymerase. The non-mutagenic methylated parental DNA template was digested with DpnI. The resultant circular nicked double-stranded DNA was transformed into XL10-Gold ultra competent cells (Stratagene). The mutation was confirmed by sequencing of the resultant plasmids.
RESULTS

GM-CSF-stimulated Glucose Transport Depends on PI 3-Kinase-
We investigated the role of PI 3-kinase in GM-CSFstimulated transport of glucose in Xenopus oocytes expressing the human ␣GMR. Oocytes injected with ␣GMR RNA expressed ␣GMR as detected by immunoblotting using an anti-␣GMR antibody, C18 (Fig. 1A) . Reverse transcription PCR analysis indicated that Xenopus oocytes do not express a ␤GMR transcript detectable by primers specific for human ␤GMR (data not shown). Also ␤GMR protein was not detectable by immunoblotting using anti-human ␤ subunit antibody. These results are consistent with our previous finding that oocytes expressing the ␣GMR had only low affinity GM-CSF binding. Oocytes expressing the ␣GMR and incubated with 1 nM GM-CSF for 1 h showed a 2-fold increase in glucose uptake (Fig. 1B ) (27) . The increase in glucose uptake was completely inhibited by incubation with 100 nM wortmannin for 15 min prior to GM-CSF treatment, while the vehicle control buffer had no effect (Fig. 1B) . Wortmannin is a highly specific inhibitor of PI 3-kinase (39) , and the inhibitory effect of wortmannin was dose-dependent and did not affect the basal level of glucose transport. The IC 50 for inhibition of GM-CSF-stimulated glu-cose uptake by wortmannin was 2 nM (Fig. 1C) . LY294002, a structurally distinct synthetic inhibitor of PI 3-kinase, also suppressed GM-CSF-stimulated glucose uptake. At 50 M, LY294002 completely inhibited GM-CSF-induced glucose uptake with no effect on basal glucose transport (Fig. 1D) . In these experiments the vehicle control (ethanol) slightly inhibited the stimulation by GM-CSF, but the effect of LY294002 was dose-dependent with IC 50 of 2 M. These results suggest that PI 3-kinase is involved in ␣GMR-dependent signaling for glucose transport.
GM-CSF induces glucose uptake in human cells expressing the high affinity receptors ␣GMR and ␤GMR (27) . We evaluated the effect of the PI 3-kinase inhibitor wortmannin on GM-CSF-induced glucose uptake in neutrophilic HL-60 cells (40) . Cells treated with 1 nM GM-CSF showed a 2.1-fold increase in glucose uptake that was completely inhibited by 50 nM wortmannin (Fig. 1F) . These results suggest that signaling for GM-CSF-stimulated glucose uptake in cells expressing the high affinity receptor is also PI 3-kinase-dependent.
The p85 Regulatory Subunit of PI 3-Kinase Associates with
␣GMR-To investigate the mechanism of activation of PI 3-kinase pathway by ␣GMR we performed experiments to determine whether the regulatory subunit of PI 3-kinase (p85) interacts with ␣GMR. The ␣GMR monoclonal antibody S20 was used to immunoprecipitate cellular extracts from HL-60 cells treated or untreated with GM-CSF. The immunoprecipitates were analyzed by SDS-PAGE and immunoblotted with antip85 antibody. As shown in Fig. 2A , there is a ligand-independent interaction between ␣GMR and p85. The interaction between ␣GMR and p85 was confirmed by co-immunoprecipitation with an anti-p85 antibody and detected by immunoblotting with an anti-␣GMR antibody (Fig. 2B) . These results indicate a physical interaction between PI 3-kinase and ␣GMR.
Identification of a p85-binding Motif in the Cytoplasmic Domain of ␣GMR-p85 associates with ␣GMR whose cytoplasmic domain has 54 amino acid residues. We identified an SH-3 domain-binding motif consisting of a proline-rich segment (PPVP) proximal to the transmembrane domain of the ␣GMR that could potentially be an anchoring site for p85. Distal to this region near the carboxyl terminus is the only tyrosine residue in the carboxyl terminus. To investigate the role of these residues, alanine substitution mutations were introduced whereby proline-rich SH-3 domain-binding region (PPVP) was changed (AAVA) using site-directed mutagenesis to generate the plasmid ␣GMR-PA, and the tyrosine residue was mutated (Y389A) to generate the plasmid ␣GMR-YA. We also generated a truncation mutant, ␣GMR-A351, that carries a deletion of the cytoplasmic domain retaining only four amino acid residues proximal to the transmembrane domain. A schematic representation of the ␣GMR constructs is shown in Fig. 3A . Wild type or mutant plasmid cDNA was transfected into 293T cells, total cell lysates were subjected to immunoprecipitation with anti-␣GMR antibody (S20), and the immunoprecipitated proteins were analyzed by SDS-PAGE and immunoblotted using antip85 antibody. While the wild type receptor showed binding to p85, there was loss of binding to the truncation mutant ␣GMR-A351 and to the ␣GMR-PA (Fig. 3B, top panel) . The mutant ␣GMR-YA, however, retained binding, suggesting that the proline motif is critical for binding to p85 in quiescent cells. The membrane was stripped and reprobed with anti-␣GMR antibodies. C18 antibody recognizes an intracellular epitope and therefore does not recognize the truncation mutant ␣GMR-A351. Antibody S50 against an extracellular epitope was used to detect the expression of all the constructs (Fig. 3B, lower  panel) . These results point to the proline-rich motif as the site of p85 binding to ␣GMR.
The Cytoplasmic Domain of ␣GMR Is Important but Not Essential for GM-CSF-stimulated Glucose Uptake in Oocytes-
RNA from the wild type (␣GMR) and mutant plasmids ␣GMR-A351, ␣GMR-PA, and ␣GMR-YA was injected into oocytes and tested for the ability to mediate increased glucose uptake in response to GM-CSF (Fig. 4A) . GM-CSF-treated oocytes expressing wild type ␣GMR showed a 2.5-fold increase in glucose uptake; however, oocytes injected with ␤GMR RNA alone did not respond to GM-CSF. GM-CSF-stimulated glucose uptake in oocytes expressing the ␣GMR mutant ␣GMR-PA was decreased but not eliminated (Fig. 4A) . When the truncation mutant of the cytoplasmic domain of ␣GMR-A351 was used in the same experiment there was approximately a 50% decrease in the stimulated glucose uptake compared with the wild type receptor. The ␣GMR-YA mutant mediated a moderately attenuated glucose uptake compared with the wild type ␣GMR (Fig. 4A) . The expression levels of the different ␣GMR constructs were comparable (data not shown).
We addressed the question whether the residual glucose uptake induced by GM-CSF through ␣GMR-A351 is dependent on PI 3-kinase. Oocytes injected with ␣GMR-A351 and wild type ␣GMR were preincubated with wortmannin and treated with GM-CSF. As shown in Fig. 4B wortmannin inhibited the stimulation of glucose uptake in the truncation mutant. These results indicate that GM-CSF-stimulated glucose uptake is attenuated by deletion of the intracellular domain of ␣GMR but that the residual activity is also dependent on PI 3-kinase. These results imply that there is PI 3-kinase activation by GM-CSF even when p85 cannot bind to ␣GMR.
GM-CSF-induced Activation of PI 3-Kinase Involves Generation of H 2 O 2 -It is known that GM-CSF uses reactive oxygen species (ROS) as second messenger molecules in its signaling
pathway (41, 42) and that ROS in the form of hydrogen peroxide has a role in stimulating glucose uptake (43, 44) . We hypothesized that GM-CSF binding to the low affinity receptor generates H 2 O 2 extracellularly, and H 2 O 2 diffuses through the plasma membrane to activate PI 3-kinase. Oocytes expressing ␣GMR or the truncation mutant receptor ␣GMR-A351 were incubated with different concentrations of catalase for 5 min before treatment with GM-CSF. As shown in the Fig. 5A catalase markedly inhibited GM-CSF-stimulated glucose uptake indicating a key role for H 2 O 2 in stimulating glucose transport. To further establish the role of H 2 O 2 in stimulated glucose uptake we directly tested the effect of peroxide on glucose uptake in control oocytes and oocytes expressing ␣GMR constructs. Exposure to 50 M H 2 O 2 for 30 min caused about 2-fold stimulation of glucose uptake in oocytes expressing ␣GMR (Fig.  5B ). Oocytes injected with ␣GMR-A351 showed only a 1.3-fold activation in response to H 2 O 2 , a result similar to that in uninjected oocytes (Fig. 5B) . These results indicate a role for We further tested the effect of wortmannin on H 2 O 2 -induced glucose uptake in oocytes injected with ␣GMR or the truncation mutant ␣GMR-A351. As in GM-CSF-stimulated oocytes, the peroxide-induced stimulation of glucose uptake in oocytes expressing wild type or mutant ␣GMR was inhibited by 25 nM wortmannin (Fig. 5C ). These findings link peroxide generation to PI 3-kinase activation and indicate the role of p85 binding site in ␣GMR in the stimulation of glucose uptake.
Monoclonal Antibodies to ␣GMR Stimulate Glucose Transport-It has been shown that antibody-antigen interaction can lead to the generation of hydrogen peroxide (45) . We reasoned that, similar to ligand, antibody to ␣GMR could lead to the generation of H 2 O 2 and stimulation of glucose uptake. We investigated whether the commercially available anti-␣GMR antibodies S20 and 17A, which recognize the extracellular region of ␣GMR, could stimulate glucose uptake. Fig. 6A shows that anti-␣GMR monoclonal antibodies S20 and 17A stimulated glucose transport about 2-fold in oocytes injected with ␣GMR. In contrast, the polyclonal antibody N20 that recognizes an extracellular epitope of ␤GMR had no effect. Oocytes injected with H 2 O and incubated with GM-CSF, S20, 17A, and N20 antibodies showed no stimulation of glucose uptake. Oocytes expressing ␣GMR and incubated with the antibodies 17A and S20 for 15 min showed an increase in glucose uptake of about 2-fold. After 60 min of incubation, similar levels of stimulation of glucose uptake were induced by the antibodies and GM-CSF (Fig. 6B) . The stimulation of glucose uptake by S20 antibody was completely inhibited by wortmannin (Fig. 6C) , indicating that PI 3-kinase is required for antibody-as well as GM-CSF-induced glucose transport. Treatment of ␣GMR-injected oocyte with catalase also abrogated antibody-induced increase in glucose uptake (Fig. 6C) . These results indicate that antibody or ligand interaction with ␣GMR on oocytes leads to increased glucose uptake that is dependent on the generation of peroxide and subsequent activation of PI 3-kinase.
Antibody to ␣GMR Stimulates Glucose Uptake in Mammalian Cells-To extend the oocyte experiments we investigated the effect of anti-␣GMR antibodies on human cells expressing the high affinity receptor. Similar to the results in oocytes, we found that antibodies to the ␣ subunit (S20 and 17A) stimulated glucose uptake in the promyelocytic HL-60 cell line and in the monocytic cell line U937 (Fig. 7, A and B) . The antibody N20, which reacts with the ␤ subunit, had no effect on glucose   FIG. 4. Disruption of ␣GMR function by mutations in the cytoplasmic domain. A, oocytes injected with wild type ␣GMR or mutants ␣GMR-A351, ␣GMR-PA, and ␣GMR-YA were treated with GM-CSF, and glucose uptake was measured as explained under "Experimental Procedures." B, oocytes injected with wild type ␣GMR or mutants ␣GMR-A351 were treated with 0.1, 1, and 10 nM wortmannin 15 min before GM-CSF stimulation. DOG uptake is shown as pmol/oocyte. wt, wild type.
FIG. 5. Role of peroxide in GM-CS-induced glucose uptake.
A, oocytes injected with wild type ␣GMR or mutant ␣GMR-A351 were pretreated with 1900 units of catalase (1ϫ) or 3800 units of catalase (2ϫ) prior to GM-CSF stimulation. Experiments were done in triplicate, and the standard deviation is indicated. B, oocytes injected with wild type ␣GMR or mutant ␣GMR-A351 or not injected were stimulated with 50 M H 2 O 2 and then assayed for DOG uptake as described under "Experimental Procedures." C, oocytes injected with wild type ␣GMR or mutants ␣GMR-A351 or not injected were stimulated with 50 M H 2 O 2 in the presence or absence of 25 nM wortmannin and then assayed for DOG uptake as described under "Experimental Procedures." wt, wild type.
uptake. HL-60 cells treated with anti-␣GMR antibodies showed a 20% increase in glucose uptake. In U937 cells, GM-CSF and the anti-␣GMR antibodies stimulated glucose uptake to comparable levels. We also tested the effect of the antibodies on freshly isolated peripheral blood lymphocytes and observed an increase in glucose uptake in response to GM-CSF and antibodies S20 and 17A but not with antibody N20 (Fig. 7C) .
We propose a signaling pathway for GM-CSF-induced glucose uptake whereby GM-CSF receptor interaction with ligand or antibody leads to local generation of H 2 O 2 that permeates the cell membrane and activates PI 3-kinase signaling. This pathway is illustrated in Fig. 8 .
DISCUSSION
Hematopoietic cytokines stimulate the proliferation of precursor cells and promote the survival and function of mature cells. These processes require energy, and cytokines such as IL-3, lL-1, and GM-CSF are known to enhance glucose transport in target cells (19, 20, 27, 46 -48) . Transport of glucose across the plasma membrane occurs predominantly through facilitative GLUTs, and cellular glucose uptake can be modulated by regulating the number of transporters on the cell surface and/or by altering their transport efficiency (49 -52) . Both GM-CSF and IL-3 enhance the intrinsic efficiency of GLUT1 as reflected by a decrease in the K m without a change in maximum velocity (V max ) (36, 37) . GM-CSF stimulates glucose transport in Xenopus oocytes expressing the isolated human ␣GMR, HL-60 neutrophilic cells expressing the ␣␤GMR heterodimer, and certain other cell types responsive to GM-CSF (12, 26, 27, 36) . Little is known, however, about how GM-CSF signals for increased glucose uptake, and there is controversy regarding the requirement for ␤GMR (29) . Signaling from the isolated ␣GMR for glucose uptake in oocytes does not involve activation of the mitogen-activated protein kinase pathway, and GM-CSF stimulation of glucose uptake in HL-60 neutrophilic cells does not appear to involve activation of kinase pathways that are inhibitable by staurosporine (27) . More recently the in vivo relevance of GM-CSF-stimulated glucose uptake through the low affinity ␣GMR has been described in the development of preimplantation embryos in mice. These embryos express an isolated ␣GMR, and there is increased glucose uptake and enhanced proliferation and viability of blastomeres in response to GM-CSF (28) . We investigated the initial signaling events of GM-CSF-stimulated glucose uptake and sought to mechanistically define a role for the isolated ␣GMR.
In oocytes, as in mammalian cells, PI 3-kinase activation has been implicated as an important signaling intermediate for insulin-stimulated glucose uptake (53, 54) . We hypothesized that PI 3-kinase was involved in the stimulation of glucose uptake by GM-CSF. In oocytes expressing ␣GMR, GM-CSFstimulated glucose uptake was inhibited by wortmannin and a structurally distinct inhibitor of PI 3-kinase, LY294002, in a dose-dependent manner. GM-CSF-stimulated glucose uptake in HL-60 cells expressing the high affinity receptor was also blocked by wortmannin. The inhibitor results therefore implicate the involvement of PI 3-kinase in the stimulation of glu- FIG. 6 . Antibodies against the extracellular portion of the ␣GMR stimulate glucose transport. A, uptake of DOG by oocytes. Oocytes were injected with either RNA encoding the ␣GMR or water (control). After 48 h at room temperature the oocytes were incubated for 1 h with 1 nM GM-CSF (GM) or 0.4 g/ml antibodies as indicated. Uptake of DOG was quantified after 10 min. B, time course effect of GM-CSF and antibodies on DOG uptake in oocytes expressing ␣GMR. Oocytes injected with RNA encoding the ␣GMR were incubated with the antibodies indicated for 15, 30, and 60 min. The DOG uptake was determined over a 10-min period. C, effect of wortmannin and catalase on monoclonal antibody S20-induced glucose uptake. Oocytes injected with wild type ␣GMR were pretreated with 3800 units of catalase (Cat) or 50 nM wortmannin (W) before treatment with GM-CSF or monoclonal antibody S20. cose uptake signaled through ␣GMR and the ␣␤GMR high affinity receptor. We also found clear evidence for a physical interaction between ␣GMR and p85. In searching for potential domains of ␣GMR that interact with p85, we examined an SH-3 domain-binding motif, QRLFPPVP, that is conserved among the GM-CSF, IL-3, and IL-5 receptors in the intracellular membrane proximal region (17, 55) . A tyrosine residue toward the carboxyl end of ␣GMR (amino acid residue 389) is not in the context of a consensus motif used for p85 binding by certain receptors (56, 57) . Mutation of the SH-3 domain-binding site abrogated the interaction of p85 to ␣GMR as did a mutation deleting most of the cytoplasmic region of the ␣GMR. Oocytes expressing these mutants showed GM-CSF-stimulated glucose uptake of about 50% of wild type ␣GMR. This result suggested that interaction of p85 with the SH-3 domain-binding motif, while required for PI 3-kinase binding, was only partly responsible for GM-CSF-induced glucose uptake. The residual activity of the mutants was dependent on PI 3-kinase activation as it was completely blocked by wortmannin.
In several cell types insulin elicits rapid production of hydrogen peroxide (44) , and one of the subsequent cell responses to the H 2 O 2 production by insulin is increase in glucose uptake (58) . Generation of extracellular peroxide has been demonstrated previously in fibroblasts and endothelial cells treated with transforming growth factor-␤ and ROS-generating systems such as glucose/glucose oxidase or xanthine/xanthine oxidase can increase glucose uptake in 3T3-L1 adipocytes and L6 myotubes (43) . Treatment with peroxidase in these cases inhibited the increase in glucose uptake indicating that extracellular H 2 O 2 was connected to stimulation of glucose transport (43) . In addition, GM-CSF is known to use ROS for signaling (41, 42) , and ROS can act as a second messenger in cellular signaling by modifying the activity of redox-sensitive enzymes including kinases and phosphatases (59 -61) . We found that catalase and PI 3-kinase inhibitors markedly decreased GM-CSF-stimulated glucose uptake in oocytes expressing wild type or truncated ␣GMR. Hydrogen peroxide also induced PI 3-kinasedependent glucose uptake in oocytes expressing wild type and to a lesser extent the truncated ␣GMR. H 2 O 2 had some activity in stimulating glucose uptake in oocytes not expressing ␣GMR. The experiments in oocytes expressing ␣GMR yielded results consistent with the thesis that GM-CSF binding to the low affinity receptor generates H 2 O 2 , which then stimulates glucose uptake via the activation of PI 3-kinase.
Lerner and colleagues (45) have provided strong evidence for antigen-antibody interaction leading to generation of H 2 O 2 through catalysis of molecular oxygen and H 2 O. We found that anti-␣GMR antibody stimulated glucose transport in Xenopus oocytes expressing ␣GMR and also in HL-60 cells, U937, and peripheral blood lymphocytes in a wortmannin-inhibitable manner. Antibody to ␣GMR induced glucose uptake that was blocked by catalase, suggesting that peroxide production was mediating induction of glucose uptake.
The role of the ␣ subunit of the GM-CSF receptor in signal transduction through the high affinity receptor has been illuminated by mutational and structural studies (55, (62) (63) (64) ; however, there has been controversy regarding the ability of the isolated ␣GMR to signal (29) . The results reported here define a signaling system for enhanced glucose uptake dependent on H 2 O 2 generation leading to the activation of PI 3-kinase. The most proximal initiation appears to be peroxide generated from ligand or antibody interaction with the extracellular domain of ␣GMR. Permeation of peroxide leads to PI 3-kinase activation, which is facilitated by an SH-3 domain-binding motif in the cytoplasmic portion of the ␣GMR. Since most of the intracellular portion of ␣GMR is not absolutely required for PI 3-kinase activation, we envision that such activation could occur at a proximal cell membrane location. PI 3-kinase initiates well known signaling pathways; however, it is not known how it causes increased transport by reducing K m . Since vitamin C is transported as dehydroascorbic acid through GLUT1 and its uptake is stimulated by GM-CSF (37), the GM-CSFstimulated PI 3-kinase pathways can operate to enhance cellular antioxidant function as well as provide increased metabolic substrate for cellular function.
